Aridis Pharmaceuticals, Inc. (ARDS)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.0200 |
| Open | 1.0000 |
| Bid | 1.0600 x 1000 |
| Ask | 1.2100 x 1200 |
| Day's range | 0.9800 - 1.0800 |
| 52-week range | 0.8800 - 7.7200 |
| Volume | |
| Avg. volume | 102,677 |
| Market cap | 18.764M |
| Beta (5Y monthly) | 0.42 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.2630 |
| Earnings date | 10 Aug 2022 - 15 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 11.75 |
- Zacks
Aridis Pharmaceuticals (ARDS) Reports Q1 Loss, Lags Revenue Estimates
Aridis Pharmaceuticals (ARDS) delivered earnings and revenue surprises of 13.73% and 40.65%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
New Strong Sell Stocks for November 15th
ARDS, CNNE, EXK, GP, and IFF have been added to the Zacks Rank #5 (Strong Sell) List on November 15, 2021.
- Simply Wall St.
Can Aridis Pharmaceuticals (NASDAQ:ARDS) Afford To Invest In Growth?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
© 2022 Yahoo. All rights reserved.
